CDEK
← All drugs Report issue

sofinicline

Small moleculeexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Jan 1, 2007 (NCT00429091)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

Clc1cc(N2C[C@@H]3CN[C@@H]3C2)cnc1Cl
Mol. weight
244.12 g/mol
Lipinski Ro5
Pass
Rule of 3
Yes
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo(3.2.0)heptane
  • a-422894.0
  • a-422894.0
  • abt-894
  • abt-894
  • abt-894
  • abt-894
  • sofinicline
  • sofinicline
  • sofinicline
  • sofinicline

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00548925Phase 2Nov 1, 2007AbbVie
NCT00507936Phase 2Aug 1, 2007AbbVie
NCT00429091Phase 2Jan 1, 2007Abbott
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AbbVieFor profit2212007
AbbottFor profit1112007
2 organizations
Page 1 / 1